ValiRx plc (LON:VAL – Get Free Report)’s share price was up 2.9% during trading on Friday . The company traded as high as GBX 0.37 and last traded at GBX 0.35. Approximately 6,700,061 shares changed hands during trading, a decline of 7% from the average daily volume of 7,236,460 shares. The stock had previously closed at GBX 0.34.
ValiRx Stock Performance
The company has a 50-day simple moving average of GBX 0.35 and a two-hundred day simple moving average of GBX 0.42. The firm has a market cap of £2.38 million, a PE ratio of -0.34 and a beta of 0.59. The company has a quick ratio of 1.27, a current ratio of 5.50 and a debt-to-equity ratio of 0.27.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- A personal warning from Martin Weiss (Please read)
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
